Work

Beyond Genomic Alterations: Transcriptomic Profiling of Lineage Plasticity in Metastatic Solid Tumors

Year: 2026
Type: article
Abstract: Lineage plasticity allows tumor cells to shift their differentiation state during metastatic progression and treatment. Genomic profiling identifies driver alterations and clonal relationships but does not fully characterize the lineage programs expressed by metastatic lesions. This review examines the complementary role of transcriptomic profiling and histopathology in assessing changes in tumor identity, with emphasis on colorectal, pancreatic, prostate, and lung cancers. We discuss studies of lineage transformation, intermediate cellular states, and loss of lineage fidelity, and their relationship to metastatic progression and therapeutic resistance. Bulk, single-cell, single-nucleus, and spatial transcriptomic approaches provide information on malignant-cell differentiation, intratumoral heterogeneity, and microenvironmental context. Integrating these findings with morphology, immunohistochemistry, and genomic analysis may support the development of biomarkers that characterize metastatic cell states and identify programs associated with resistance. By synthesizing these findings, this review aims to clarify how RNA profiling may complement genomic and histopathological assessment of metastatic tumor identity. It also explores how lineage-associated programs could inform diagnostic biomarkers and therapeutic strategies, including modification of plastic states or targeting of their acquired dependencies. The review discusses the analytical and clinical evaluation needed to connect these biological findings with the assessment of metastatic biopsies.
Source: Diagnostics
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7235899178
FWCI:
Cites: 66
Cited by:
Related to: 10